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Abstract
Aims
Infiltration of macrophages and apoptosis of vascular smooth muscle cells (VSMCs) pro-
mote the development of abdominal aortic aneurysm (AAA). Previously, we demonstrated
that global Notch1 deficiency prevents the formation of AAA in a mouse model. Herein, we
sought to explore the cell-specific roles of Notch1 in AAA development.
Methods and results
Cell-specific Notch1 haploinsufficient mice, generated on Apoe-/- background using Cre-lox tech-
nology, were infused with angiotensin II (1000 ng/min/kg) for 28 days. Notch1 haploinsufficiency
in myeloid cells (n = 9) prevented the formation of AAA attributed to decreased inflammation.
Haploinsufficiency of Notch1 in SMCs (n = 14) per se did not prevent AAA formation, but his-
toarchitectural traits of AAA including elastin degradation and aortic remodeling, were minimal in
SMC-Notch1+/-;Apoe-/- mice compared to Apoe-/- mice (n = 33). Increased immunostaining of
the contractile SMC-phenotype markers and concomitant decreased expression of synthetic
SMC-phenotype markers were observed in the aortae of SMC-Notch1+/-;Apoe-/- mice. Expres-
sion of connective tissue growth factor (CTGF), a matrix-associated protein that modulates the
synthetic VSMC phenotype, increased in the abdominal aorta of Apoe-/- mice and in the adventi-
tial region of the abdominal aorta in human AAA. Notch1 haploinsufficiency decreased the exp-
ression of Ctgf in the aorta and in vitro cell culture system. In vitro studies on SMCs using the
Notch1 intracellular domain (NICD) plasmid, dominant negative mastermind-like (dnMAML), or
specific siRNA suggest that Notch1, not Notch3, directly modulates the expression of CTGF.
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Conclusions
Our data suggest that lack of Notch1 in SMCs limits dilation of the abdominal aorta by main-
taining contractile SMC-phenotype and preventing matrix-remodeling.
Introduction
Abdominal aortic aneurysm (AAA) is a localized dilation of the abdominal aorta exceeding
the normal diameter by more than 50% of its original size[1, 2]. The prevalence of AAA ranges
from 1.3% in men 45 to 54 years of age to ~9% in the population over 65 years of age[2, 3]. In
the United States, aortic aneurysms account for more than 10,000 deaths per year[2]. Under-
standing the underlying mechanisms of AAA expansion will lead to novel pharmacologic ther-
apies to reduce AAA development and rupture[4–6].
The development of AAA is characterized by transmural infiltration of macrophages and
depletion of vascular smooth muscle cells (VSMCs) at the vascular injury site, which results in
the focal enlargement of the abdominal aorta[7–10]. Excessive infiltration of macrophages and
apoptosis of VSMCs stimulates activation of matrix metalloproteinases (MMPs) resulting in
the fragmentation of the elastin and interstitial collagenous matrix of the medial layer of the
aorta[11]. VSMCs are capable of phenotypic modulation in response to different environmen-
tal cues. Contractile and synthetic VSMCs, which represent the two ends of a spectrum, have
different morphological components and functional roles[12]. Contractile VSMCs are quies-
cent cells, display an elongated spindle-shaped morphology and express a unique repertoire of
contractile proteins that serve as VSMC markers including SMA- α, SM22α, smMHC and
smoothelin[13, 14]. Vascular injury, results in abundant proliferative and migratory pheno-
typic modulation of VSMCs, which produce extracellular matrix (ECM) proteins such as elas-
tin and collagen to provide tensile strength to the injured vessel wall. However, enhanced
degradation of structural proteins, together with a reduced capacity to synthesize new matrix
proteins, progressively weaken the aortic wall, resulting in rupture.
Notch1 signaling has gained substantial interest in the past few years because of its involve-
ment in multiple aspects of vascular development and remodeling including myeloid and
VSMC differentiation[15–23]. Notch1 signaling also regulates vascular inflammation[24],
VSMC apoptosis[25, 26], and MMP-dependent proteolysis[27, 28]. Many of these pathways
are implicated in the pathogenesis of aneurysms[29]. There are four types of Notch receptors
(Notch1-4) expressed in all vascular cells including endothelial cells, VSMCs and macrophages
[30]. Upon ligand receptor binding (Jagged or Delta-like), the Notch intracellular domain
(NICD; active form of Notch1) is released from the membrane and is translocated into the
nucleus where it binds to the transcriptional regulator RBPJ (also known as CBF-1). NICD
activates the transcription of target genes by displacing the repressor complex from CBF-1
genes and recruiting activators including mastermind-like protein (MAML)[31]. Our labora-
tory identified Notch1 signaling as an important factor that mediates inflammatory response
and disease initiation in angiotensin II (AngII) induced mouse model of AAA[32, 33]. We also
reported that reconstitution of bone marrow-derived cells from Notch1+/-;Apoe-/- mice (donor)
in irradiated Apoe-/- mice (recipient) decreased the occurrence of aneurysm[33]. The diversi-
fied roles of Notch1 in various vascular cells demonstrate the complexity of Notch signaling
and warrant studying the individual contributions of the Notch1 receptor in each vascular cell
type on aneurysms.
The goal of this study was to define the unique contributions of SMC-specific and myeloid-
specific Notch1 signaling in the development of AAA. We present evidence that myeloid-
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specific Notch1 haploinsufficiency protects against the formation of AAA, whereas SMC-spe-
cific Notch1 haploinsufficiency interferes with the progression of aortic aneurysms. Collec-
tively, these findings imply that Notch1 signaling in different cell types affects the development
of aortic aneurysm by multifarious mechanisms and represents a potential target to mitigate
the deleterious effects of AAA at different stages of the disease progression.
Materials and methods
To determine the contributions of each vascular cell type in AAA development, we used a Cre-
Lox recombination approach. The following cell-specific Notch1 haploinsufficient mice were
generated:
1. Myeloid specific Notch1 haploinsufficient mice (LysM-Cre).
2. Smooth muscle cell (SMC) specific Notch1 haploinsufficient mice (smMHC-Cre).
3. Endothelial cell (EC) specific Notch1 haploinsufficient mice (Tie2-Cre).
The LysM-Cre, smMHC-Cre, and Tie2-Cre mice were purchased from Jackson lab (Ann
Arbor). Cell specific Notch1 haploinsufficient mice were generated by crossing the offspring of
Notch1flox/WT;Apoe-/- female mice with their respective Cre male mice against Apoe-/- back-
ground as explained in S1 Table. All animals were genotyped by polymerase chain reaction
(PCR) as shown in S2 and S3 Tables). Aneurysmal studies were performed on these mice by
infusing AngII or saline for 28 days using published protocols[32, 33]. Briefly, mice were anes-
thetized in a closed chamber with 3% isoflurane in oxygen for 2 to 5 minutes until immobile.
Each mouse was then removed, and taped on a heated (35–37˚C) procedure board with 1.0–
1.5% isoflurane administered via nosecone during minor surgery. After 28 days, mice were
deep anesthetized with ketamine/xylazine (100 and 20 mg/kg, respectively) the aortae were dis-
sected, fixed in 10% formalin, and maximal aortic diameters measured. The animal experi-
ments were approved by Institutional Animal Care and Use Committee at the Research
Institute at Nationwide Children’s Hospital. All the animal experiments conform the NIH
guidelines (Guide for the care and use of laboratory animals).
Isolation, culture, flow cytometry and co-culture of primary abdominal
aorta-derived vascular smooth muscle cells (VSMCs) and bone marrow
derived macrophages
Primary abdominal aorta-derived VSMCs were isolated from WT, Notch1+/-, Apoe-/- or
Apoe-/-;Notch1+/- mice (6–8 weeks of age). Briefly, mice were sacrificed with CO2 asphyxiation
and perfused with ice cold PBS through the left ventricle. Abdominal aorta was isolated and
cleared from exogenous fat and adventitial layer followed by enzymatic digestion using colla-
genase/elastase (1 mg/mL collagenase, cat# LS004174, 0.744 units/mL elastase, cat# LS002279;
Worthington) as described[34, 35]. VSMCs were grown in DMEM/F12 media without phenol
red with 2% penicillin/streptomycin, 1% fungizone (Invitrogen), and 20% fetal bovine serum
(Tissue Biologics) until cells were confluent, and then trypsinized (0.25%). Purity of SMC was
confirmed by performing immunofluorescence on the isolated cells with antibodies to smooth
muscle actin (SMA-α) as shown in our previous studies [35, 36]. All studies with VSMCs were
performed on cells from passage 3–8. For apoptosis assay, VSMC were grown on 6 well plates.
At ~70% confluence, the cells were treated with 1% FCS in DMEM containing lipopolysaccha-
ride (LPS;100 ng/ml) for 24 hours. Afterwards, cells were stained with Annexin V Apoptosis
Detection Kit (eBiosciences) using standard protocols. Flow cytometry was performed on a
Becton Dickinson LSRII flow cytometer with DiVa software and data were analyzed with Flow
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Jo software (Ashland, OR) to quantify the percentage of differential apoptotic population. For co-
culture assay, the bone marrow–derived macrophage (BMDMs) were isolated from Notch1+/- and
wild-type (WT)mice and differentiated to naïve macrophages onto transwell chambers using the
standard protocol[32, 33]. The cells were then pretreated with vehicle or LPS (100 ng/ml) and
interferon-γ (IFN-γ; 20 ng/ml) for 3h, as described [37]. After pretreatment, the transwell cham-
bers containing BMDMs were washed with media to remove excess of LPS/IFN-γ, and were
transferred to another plate in which WT SMCs were previously grown at the ratio of 1:1. After
24 hours, the SMCs were washed and RNA was isolated for further experiments.
Transfection of smooth muscle cells
Plasmids and siRNA sequences were used for transfecting the cells. NICD and dnMAML plas-
mids were obtained from Dr. Lilly’s laboratory. Predesigned Notch1 (s70698, Invitrogen) and
Notch3 (s70707, Invitrogen) siRNA were used with Lipofectamine 3000 (L3000, Invitrogen)
and Lipofectamine RNA iMAX (13778, Invitrogen). The cells were plated into 6-, 12-, or
24-well plates with their normal growth serum. Two hours prior to the transfection, DMEM
media without serum and antibiotics were added to the cells. The reagents for transfection
were prepared using OptiMEM media (31985–070, Invitrogen). Two different tubes were pre-
pared for each well; one containing the OptiMEM and Lipofectamine P3000 and the other
containing OptiMEM, Lipofectamine P3000/RNA iMAX reagent, and either the plasmid (2μl/
μg DNA) or the siRNA. These two tubes were then combined and the mixture was incubated
for 5 minutes at room temperature. This mixture was then added directly onto the cells con-
taining the DMEM serum-free and antibiotic-free media. The media was changed four to six
hours after transfection with normal growth medium.
Human aortic tissue samples
After written informed consent, full thickness infrarenal abdominal aortic wall tissue samples
were collected from patients who underwent repair operations for AAA (n = 3, white men aged
67, 70, and 72 years) at the Harper University Hospital, Detroit, Michigan. Non-aneurysmal con-
trol samples were collected from the infrarenal segment of aorta (n = 3; white men aged 53, 53,
and 78 years) at autopsies within 24 hours of death at the Detroit Coroner’s Office. The samples
were considered discarded tissue samples and no consent was required for the autopsy samples.
At the time of harvesting, all samples were coded and no link to personal identifying information
was kept. Tissue samples were incubated in phosphate-buffered formalin and embedded in par-
affin for histological and immunohistochemical analyses. The collection of the tissue samples
and their use for research projects was approved by the Institutional Review Board of Wayne
State University, Detroit, Michigan, and the research carried out was in compliance with the Hel-
sinki Declaration[32].
Histology, immunostaining, and quantitation
The mice from the experiments were euthanized and aortae were dissected. The thoracic and
abdominal aortae were fixed in 10% formalin and serial sections were obtained. The abdomi-
nal aorta was cut into two equal halves and serial sections of the abdominal aorta (5μM) were
prepared throughout the aneurysmal area of the abdominal aorta. Several sections of the
abdominal aorta at regular intervals (200μM) were subjected to hematoxylin and eosin (H&E),
elastin, and Masson’s trichrome stain for histoarchitectural evaluation of aneurysm. The serial
tissue sections obtained from these mice were further subjected to immunohistochemistry
(IHC) or immunofluorescence (IF). For IHC, the abdominal aortae were stained with antibod-
ies for active caspase-3, matrix metallopeptidase-2 (Mmp2), Mmp9, Mmp12, smooth muscle
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myosin heavy chain (smMHC), alpha-smooth muscle actin (SMA- α), osteopontin, vimentin,
connective-tissue growth factor (Ctgf), NICD, interferon regulatory factor 8 (Irf8), Cd206, and
monocyte chemotactic protein-1 (Mcp1). The intensity of the immunostaining was evaluated
by obtaining 4–5 images from random areas of interest at 40X from each tissue (n = 4) and
quantified using ‘Fiji’ version of Image J following the software directions[38]. For IF, CTGF
and anti-fibroblast TE-7 were used to co-stain the sections of the human tissue. Antifade
Mounting Medium containing DAPI (Vector Laboratories) was used to stain nuclei and
mount the slides. The specificity of the antibody staining was determined using non-specific
IgG against the source of host species. IHC and IF was performed using protocols described in
a previous study[32, 33]. The list of antibodies can be found in S4 Table.
Protein isolation and Western blot
Total proteins were extracted from the cells with RIPA buffer supplemented with protease and
phosphatase inhibitor cocktails (Roche). After homogenization, protein concentrations were
measured and 20 μg of protein were loaded onto 10% SDS-polyacrylamide gel, and transferred
to PVDF membrane using standard protocols. The membranes were probed for CTGF and
NICD using specific antibodies using standard protocol[35–37, 39]. GAPDH antibody was
used for internal loading control.
RNA isolation and qRT-PCR
Total RNA was isolated from the primary cell lines and the aortic tissue (suprarenal aorta
approximately 5 mm thick) using TRIzol reagent (Ambion) according to manufacturer’s pro-
tocol. The aortic tissue samples were first homogenized using TissueLyser II (Qiagen). Isolated
RNA underwent a DNAse treatment using DNAse Treatment and Removal reagent (Ambion)
to remove contaminating genomic DNA. cDNA was synthesized using the SuperScript VILO
kit (Invitrogen) and subjected to quantitative PCR (qPCR) by SYBR Green (Applied Biosys-
tems) using an Applied Biosystems 7500 Fast Real-Time PCR System. The samples were run
in triplicate and the fold-change was determined by normalizing CT values against Rpl13a.
The primers are listed in S5 Table.
Vascular smooth muscle cell contractility assay
The ability of cells to contract a collagen gel matrix was determined using a 96-well collagen
gel contraction assay using standard protocol[40]. Aortic VSMCs isolated from Apoe-/- or
Notch1+/-;Apoe-/- mice were first cultured in a 6-well plate and treated with or without 10 ng/
ml CTGF for 72 hours. Cells were then trypsinized, counted, and suspended in a collagen solu-
tion at a concentration of 6x105 cells/ml. This collagen solution contained the following: 43%
(v/v) sterile PBS (Hyclone), 34% (v/v) 3 mg/ml rat tail collagen (BD Biosciences), 13.6% (v/v)
serum-free DMEM (Hyclone), 7.6% (v/v) 10x Medium 199 (GIBCO), and 1% (v/v) FBS (Med-
iatech). The solution was brought to neutral pH (~7.0) by addition of NaOH using the phenol
red indicator in the DMEM. Then, 70 μl of this collagen+cell solution was loaded into the
wells of a 96-well plate and incubated at 37˚C for 30 minutes to allow collagen to polymerize.
A total of 140 μl of DMEM with 2% FBS was then added and the wells were incubated for 48
hours. The gels were then gently released from attachment to walls of the wells by Dumont #55
Forceps and 0 hour images were taken. The media was then replaced with 10% FBS DMEM to
induce contraction and incubated for further 2 hours. After 2 hours, another image was taken
of each well to determine the amount of gel contraction. Each treatment group was repre-
sented by 6 replicates in each experiment, and repeated in 3 independent experiments. The
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images were analyzed using ImageJ software[41] to measure the gel area at each time-point,
from which the percentage decrease of gel area was determined[42].
Aortic ring assay
Aortae from Apoe-/- male mice were isolated. These aortae were dissected to obtain 4–5 sec-
tions (rings) from the abdominal region for transfection. The aortic rings were treated with
the following in the absence or presence of CTGF (Invitrogen): NICD and dnMAML plasmid
(along with the empty vector), non-specific siRNA (4390846, Invitrogen), siRNA Notch1
(s70700, Invitrogen), and siRNA Notch3 (s70708, Invitrogen) using standard protocol[43].
Plasmids and pre-designed siRNA were transfected with Lipofectamine 3000 and Lipofecta-
mine RNAiMAX, respectively. The rings were plated onto chamber slides in DMEM High
Glucose media (Hyclone) with 10% FBS (Fisher Scientific). Two hours prior to the transfec-
tion, DMEM media without serum and antibiotics were added to the chamber slides. The
reagents for transfection were prepared using OptiMEM media (Invitrogen). Two different
tubes were prepared for each well; one containing the OptiMEM and Lipofectamine 3000 or
RNA iMAX and the other containing OptiMEM, P3000 reagent, and either the plasmid or the
siRNA. These two tubes were then combined and the mixture was incubated for 5 minutes at
room temperature. This mixture was the added directly onto the chamber slides with the aortic
rings containing the DMEM serum-free and antibiotic-free media. The media was changed 24
hours after transfection to DMEM High Glucose media with 10% FBS. The aortic rings were
then treated using recombinant human CTGF protein (PHG0286; Gibco) for additional 48
hours. The rings were then collected and processed for histology.
Statistical analysis
Statistical comparisons were performed using either the Student t-test or 1-way ANOVA fol-
lowed by the Bonferroni multiple comparison correction. GraphPad Prism version 5.0 (Graph-
Pad Software, Inc., CA) was used for these comparisons and P<0.05 was considered significant.
Assumptions of normality and equal variance were tested and satisfied using SAS software ver-
sion 9.3 (SAS Institute Inc., NC). For multiple comparisons, a post-Bonferroni test with Holm
correction (for 3 comparisons) was performed for maximal aortic width graph and survival
graph. For the real-time RT-PCR quantification, we performed the Kruskal–Wallis test using a
non-parametric method for the overall significance of the data and ordinary ANOVA followed
by a Bonferroni-Holm multiple comparisons test with single-pooled variance for multiple com-
parisons using GraphPad Prism version 5.0. For the statistical analysis of actual incidence, Fish-
er’s exact test was used with the SAS software. The actual incidence of the disease is defined as
50% of greater increase in the maximal aortic width compared with the control group.
Results
Cell-specific Notch1 haploinsufficiency differentially interferes with AAA
development in AngII-induced mouse model
To determine the contributions of SMCs, ECs, and macrophages in AAA development, we used
the Cre-Lox recombination approach. The macroscopic quantification of the external diameter of
suprarenal aorta demonstrated a significant exacerbation in maximal aortic width of Apoe-/- mice
with AngII treatment to 2.37 ± 0.58 mm (n = 24, P<0.001; Fig 1B, 1E and 1F) compared to saline
treated Apoe-/- mice (1.10 ± 0.10 mm; n = 6; Fig 1A). No difference in the littermate controls was
observed in the Apoe-/- mice for each Cre or Notch1flox/wt with regard to aneurysm, hence all these
mice are pooled in one group (n = 33). The maximal aortic width in myeloid-Notch1+/-;Apoe-/-
Cell-specific Notch1 haploinsufficiency
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Fig 1. Cell-specific Notch1 haploinsufficiency differentially interferes with AAA development in AngII-induced mouse
model. Representative aortae isolated from Apoe-/- mice treated with saline (A), AngII (B), SMC-Notch1+/-;Apoe-/- mice (C;) and
Cell-specific Notch1 haploinsufficiency
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mice remained significantly lower as compared to AngII-treated Apoe-/- mice and was comparable
to saline-infused Apoe-/- mice (0.97 ±0.18; n = 7, P<0.001, Fig 1D and 1F). Interestingly, in SMC-
Notch1+/-;Apoe-/- mice, dilation of aorta increased moderately and remained in a narrow range. At
day 28 the maximal aortic width in SMC-Notch1+/-;Apoe-/- mice was modestly but insignificantly
lower than AngII-treated Apoe-/- mice (1.83 ± 0.47; n = 7, Fig 1C, 1E and 1F). The maximal aortic
width in EC-Notch1+/-;Apoe-/- mice was comparable to AngII-treated Apoe-/- mice (S1 Fig; n = 7).
Overall, AngII treatment resulted in 27% mortality in Apoe-/- mice within 10 days of the treatment
(Fig 1G). In SMC-Notch1+/-;Apoe-/- mice, 50% mortality was observed and occurred within 7 days
of treatment, but was not statistically significant as compared to Apoe-/- mice with AngII treat-
ment (Fig 1G), which may be attributed to either initial influx of Notch1 sufficient macrophages
at the vascular lesion or some unrelated effects of Notch1-haploinsuffiiciency[44]. In our studies,
the aortae from dead SMC-Notch1+/-;Apoe-/- mice had dissection in the thoracic region. Indeed,
various studies have shown strong correlation between Notch1 mutation and thoracic aortic an-
eurysm (TAA) suggesting that TAA and AAA represent a very complex pathology with regard-
ing to Notch1 signaling pathway[45–47]. Interestingly, the dilation of proximal aorta in the
ascending aorta and arch was comparable in Apoe-/- and SMC-Notch1+/-;Apoe-/- mice at day 28
of AngII treatment and was larger than in myeloid-Notch1+/-;Apoe-/- mice (S2 Fig). The trend in
the mortality in EC-Notch1+/-;Apoe-/- mice was similar to SMC-Notch1+/-;Apoe-/- mice (S1 Fig).
The mortality in myeloid-Notch1+/-;Apoe-/- mice was comparable to Apoe-/- mice in response to
AngII (33%), whereas no deaths were observed in the saline-treated mice (Fig 1G). Summariz-
ing these findings, Notch1 haploinsufficiency in macrophages is sufficient to prevent the forma-
tion of AAA in Apoe-/- mice in response to AngII, whereas Notch1 haploinsufficiency in SMCs
may interefere with the progression of AAA.
Cell-specific Notch1 haploinsufficiency prevents elastin degradation and
limits matrix metalloproteinase production
The mouse experimental tissues were examined histologically for the characteristic architecture
and distinct features of aneurysm. HE staining of the abdominal aorta after 28 days of AngII
infusion in Apoe-/- mice showed dilation of the aortic wall, inflammatory cell infiltration, and
disarrangement of ECM with clear signs of elastin fragmentation (Fig 2B, 2F and 2J) as com-
pared to saline-infused Apoe-/- mice (Fig 2A, 2E and 2I). No such histoarchitectural features of
aneurysm were observed in the aortae of myeloid-Notch1+/-;Apoe-/- mice infused with AngII
(Fig 2D, 2H and 2L) which displayed a well-defined lumen, no visible elastin fragmentation and
minimal inflammatory cell infiltration. SMC-Notch1+/-;Apoe-/- mice depicted a distinct mor-
phology of abdominal aorta associated with moderate adventitial thickening, marginal aortic
remodeling and no visible signs of elastin fragmentation (Fig 2C, 2G and 2K). Moderate to high
collagen content was observed in the adventitial region of abdominal aorta in AngII-treated
Apoe-/- mice (Fig 2N) as compared to Apoe-/- mice treated with saline (Fig 2M). Collagen con-
tent in the adventitial aorta of SMC-Notch1+/-;Apoe-/- mice were comparable to AngII-treated
Apoe-/- mice (Fig 2O). However, the mRNA expression Col1α1,Col1α2, and Col3α1 increased
disproportionately by almost 4-fold in response to AngII in Apoe-/- mice compared with AngII-
treated SMC-Notch1+/-;Apoe-/- mice, suggesting increased collagen degradation and turnover in
myeloid-Notch1+/-;Apoe-/- mice (D;) treated with AngII (28 days). Images were taken using Zeiss Stemi 2000-C microscope. Scale
bar, 1 mm. (E-F), Quantitative measurement of maximal aortic width (mm) in different groups. Each symbol represents an individual
animal. Mean and SEM are shown. (G) Survival graph showing the mortality of individual mice in each group during 28 day AngII
infusion. ***P<0.001 (post-Bonferroni test with Holm correction).
https://doi.org/10.1371/journal.pone.0178538.g001
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Fig 2. Cell-specific Notch1 haploinsufficiency in vascular smooth muscle cells and macrophages protects against extensive structural
damage and collagen deposition in the abdominal aortic wall in response to AngII (28 days) treatment. (A-D) Cross-section of representative
Cell-specific Notch1 haploinsufficiency
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the former group (Fig 2Q–2S). Collagen content was not considerably altered in the aortae of
myeloid-Notch1+/-;Apoe-/- mice infused with AngII (Fig 2P–2S).
MMPs have been implicated in degrading a wide range of ECM proteins in vascular dis-
eases including AAA. As assessed by the IHC, a high immunoreactivity of Mmp2 and Mmp9
was observed throughout the medial and adventitial layers of abdominal aorta of Apoe-/- mice
with AngII treatment (S3B and S3F Fig) as compared to saline treated Apoe-/- mice (S3A and
S3E Fig). In contrast, minimal Mmp2 and Mmp9 immunoreactivity was present in the abdom-
inal aortae of SMC-Notch1+/-;Apoe-/- and myeloid-Notch1+/-;Apoe-/- mice in response to AngII
(S3C, S3D, S3G and S3H Fig).
Apoptotic cell death and depletion of medial SMC has been shown to play an important
role in human AAA pathological samples and in mouse aneurysmal models[48, 49]. Immuno-
histochemical analyses showed increased active caspase-3 immunoreactivity in the medial
layer of aorta in the Apoe-/- mice infused with AngII compared with saline treated Apoe-/- mice
(S3I and S3J Fig). Minimal active caspase-3 immunostaining was observed in the abdominal
aorta of SMC-Notch1+/-;Apoe-/- and myeloid-Notch1+/-;Apoe-/- mice (S3K and S3L Fig). Apopto-
tic cell death of LPS-stimulated VSMC isolated from the abdominal aorta of Notch1+/-;Apoe-/-
mice was also decreased as compared to Apoe-/- mice as detected by FACS analysis using
annexin V-propidium iodide (PI) staining (S4A–S4C Fig). These data suggest that SMC- and
myeloid-specific Notch1 haploinsufficiency impact the pathological sequelae associated with
AAA by different mechanisms. In following experiments, we focused on the mechanism by
which SMC-specific Notch1 haploinsufficiency interferes with the development of AAA.
Shift in SMC phenotype in SMC-specific Notch1 haploinsufficient mice is
associated with decrease in CTGF expression
Nuclear Notch1 staining representing active NICD was observed in the aortae of Apoe-/- mice
(arrows in S5B Fig). The medial layers of aortae in SMC-Notch1+/-;Apoe-/- mice were devoid of
such nuclear Notch1 staining (arrows in S5C Fig). Surprisingly, no nuclear NICD staining was
observed in the medial layer of myeloid-Notch1+/-;Apoe-/- mice in spite of cytoplasmic presence
of NICD (arrows in S5D Fig). The results confirm that depletion of Notch1 signaling reduces
the expression of Notch1 activity in respective cell-specific Notch1 haploinsufficient mice. We
previously reported that Notch1 deficiency protects against AAA development by reducing M1
polarization of Mφ[32, 33]. Increased expression of Irf8 and Mcp1 was observed in the abdomi-
nal aortae of Apoe-/- mice in response to AngII (S5E–S5L Fig). The expression of these cytokines
was minimal in the aorta of myeloid-Notch1+/-;Apoe-/- mice, with concomitant increase in the
expression of Cd206. SMC-Notch1+/-;Apoe-/- mice depicted a distinct phenotype with regard to
the expression of macrophage polarization. Whereas, the expression of Irf8 and Mcp1 was com-
parable to Apoe-/- mice in response to AngII, the expression of Cd206 was also increased in the
adventitia suggesting heterogeneity in the macrophage population (S5G, S5K and S5O Fig). The
gene expression of iNos (a M1 macrophage marker) was significantly increased in the Apoe-/-
mice in response to AngII compared to other groups, whereas in the myeloid-Notch1+/-;Apoe-/-
mice, expression of Arg1 (a M2 macrophage marker) was significantly increased compared to
the other groups (S5Q and S5R Fig).
aortae stained with hematoxylin and eosin (HE) staining showing lumen and intraluminal thrombus. Panel (E-H) Representative photomicrographs
showing transmural inflammatory cell infiltration. (I-L) Representative images of modified Verhoeff Van Gieson staining demonstrating the extent of
elastin fragmentation; (M-P) Collagen contents in the abdominal aorta of experimental groups visualized in blue using trichrome staining. Scale
bar = 50 μm in A-P. (Q-S) Bar graphs represent gene expression of Col1α1, Col1α2 and Col3α1 in the aortae of the Apoe-/- and cell-specific Notch1
haploinsufficient Apoe-/- mice after 28 days AngII treatment. The results were standardized to Rpl13a and reported as ratio (mean ± SEM, n = 3 for
each group) to saline-treated mice. ***P<0.001 (ordinary ANOVA followed by a Bonferroni-Holm multiple comparisons test).
https://doi.org/10.1371/journal.pone.0178538.g002
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Next, we examined the factors that define a contractile or synthetic SMC phenotype. Expres-
sion of the contractile markers smMHC and SMA-α were highly expressed in the aortae of con-
trol Apoe-/- mice (Fig 3A and S6A Fig). Decreased immunoreactivity for smMHC and SMA-α
was observed in the medial layer of abdominal aorta in response to AngII in Apoe-/- mice (Fig 3B
and 3E and S6B Fig). Notch1 haploinsufficiency in SMCs prevented such loss in the contractile
SMC-phenotype markers (Fig 3C, and S6C Fig). Remarkably, the adventitial thickening observed
in these groups was also associated with increased expression of smMHC and SMA-α, and was
completely absent in the Apoe-/- mice in response to AngII (red arrows in Fig 3C and 3E and S6C
Fig). Expression of contractile markers in the myeloid-Notch1+/-;Apoe-/- mice was similar to
SMC-Notch1+/-;Apoe-/- mice (Fig 3D and 3E and S6D Fig). However no migration of these con-
tractile SMCs was observed in the adventitia of myeloid-Notch1+/-;Apoe-/- mice. Conversely, the
expression of osteopontin and vimentin, markers of a synthetic-SMC phenotype was increased
with AngII infusion primarily in the adventitial region in the aorta of Apoe-/- mice (Fig 3F and 3J
and S6F Fig). The expression of these synthetic-SMC markers was minimal in the abdominal
aorta of SMC-Notch1+/-;Apoe-/- mice. In the myeloid-Notch1+/-;Apoe-/- mice, the expression of
osteopontin appears to be similar to Apoe-/- mice with AngII infusion. Mmp12 plays an impor-
tant role in SMC migration and proliferation during vascular remodeling. As shown in Fig 3K–
3O, AngII caused induction of Mmp12 expression in both medial and adventitial layers of
abdominal aorta in the Apoe-/- mice compared to control mice. No such increase in Mmp12
expression was observed in the abdominal aortae of SMC-Notch1+/-;Apoe-/- mice in response to
AngII (Fig 3M).
Connective tissue growth factor (CTGF), secreted by synthetic VSMCs and fibroblasts, is a
potent ECM–inducing growth factor involved in regulating aneurysm-associated vascular
remodeling[50, 51]. We examined if Notch1 haploinsufficiency in SMCs is associated with
alterations in Ctgf expression. Minimal immunostaining of Ctgf was observed in the saline
infused Apoe-/- mice (Fig 3P). In response to AngII, Ctgf immunoreactivity markedly increased
in the abdominal aorta of Apoe-/- mice (Fig 3T) and the distribution was similar to osteopontin
and vimentin expression. Moderate expression of Ctgf was also observed in the aorta of mye-
loid-Notch1+/-;Apoe-/- mice with AngII treatment (Fig 3Q and 3T). Immunoreactivity of Ctgf
was minimal in the aorta of SMC-Notch1+/-;Apoe-/- mice, suggesting a phenotypic shift with
SMC-specific Notch1 haploinsufficiency (Fig 3R). Next, we examined if Notch1 deficiency causes
any alterations in the gene expression of canonical Tgf-β signaling, an upstream regulator of Ctgf
pathway. Gene expression of Ctgf,Opn, Mmp12, Tgf-β1and Tgf-β2was increased in the aorta of
Apoe-/- mice with AngII infusion (Fig 3U–3Y). Myeloid-specific Notch1 haploinsufficiency did
not prevent such an increase in the gene expression of Ctgf and Tgf-β1. In fact, the expression of
Tgf-β2was even higher in myeloid-Notch1+/-;Apoe-/- mice than Apoe-/- mice with AngII. Con-
versely, the expression of Ctgf,Tgf-β1and Tgf-β2was significantly decreased in the aortae of
SMC-Notch1+/-;Apoe-/- mice as compared to Apoe-/- mice (Fig 3W–3Y). Expression of Smad2, a
downstream target of Tgf-β2 signaling was also increased in Apoe-/- mice and myeloid-Notch1+/-;
Apoe-/- mice with AngII treatment and was significantly reduced in SMC-Notch1+/-;Apoe-/- mice
(Fig 3Z). Surprisingly, expression of Smad3 was significantly increased in SMC-Notch1+/-;Apoe-/-
mice (Fig 3AA). The gene expression of Ctgf was also lower in the SMCs isolated from the
abdominal aorta of Notch1+/-;Apoe-/- mice as compared to Apoe-/- mice at basal conditions or in
the presence of TNF-α (10 ng/ml for 24 hours; Fig 3A and 3B).
CTGF has been shown to be a direct modulator of the VSMC phenotype in vascular diseases
in human[50]. A significant increase in CTGF-expressing cells was observed in AAA in the
inflammatory regions compared with non-inflammatory regions in the same AAA tissue or in
the aorta of control human subjects (Fig 4A–4D). The inflammatory and non-inflammatory
regions in these tissues were recognized by the presence of macrophages and other inflammatory
Cell-specific Notch1 haploinsufficiency
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Fig 3. SMC-specific Notch1 haploinsufficiency dependent regulation of SMC phenotype is associated with changes in CTGF
expression. Representative images of IHC staining of abdominal aorta from respective experimental groups with antibodies against smMHC
Cell-specific Notch1 haploinsufficiency
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cells[32]. Next, we examined if increased CTGF expression is associated with synthetic SMC-
phenotype in the aorta of human AAA patients. Co-immunostaining with a highly specific TE-7
antibody which identifies fibroblast-like synthetic SMCs[52] suggests that CTGF expression is
highly correlated with fibroblast-like synthetic SMC-phenotype (Fig 4E–4P). To further examine
if macrophages modulate SMC-phenotype, we performed co-culture assay. The SMCs were
obtained from the abdominal aorta of wild type (WT)mice and bone marrow derived macro-
phages (BMDMs) were isolated from either WT or Notch1+/- mice. The BMDMs were pretreated
with LPS/IFN-γ to polarize them into pro-inflammatory M1 phenotype as explained [32, 33]. As
the data demonstrate, naïve BMDMs from either WT or Notch1+/- mice did not affect the expres-
sion of smMHC, Ctgf,Mmp12, or vimentin in SMCs. Co-culture with BMDMs, pre-treated with
LPS/IFN-γ showed no significant changes in the expression of Mmp12 or vimentin. The expres-
sion Ctgf and smMHC, however was decreased in the WT SMCs in response to co-culture with
Notch1+/- BMDM pretreated with LPS/IFN-γ. These data support the hypothesis that Notch1
deficiency may be directly regulating SMC phenotype and that these effects may be mediated
independent of its effects on macrophage polarization.
Gain- and loss-of-function studies suggest direct involvement of Notch1
in regulating CTGF expression
TGF-β2 is a potent stimulator of SMC phenotypic modulation and is also upstream of CTGF sig-
naling. We determined if Notch1 is upstream regulator in the Tgf-β2 mediated regulation of
CTGF. First, we confirmed the expression of CTGF in cultured human aortic SMCs (hASMCs)
and mouse primary fibroblasts at basal levels and in response Tgf-β2 agonist or antagonist. At
basal conditions, very low expression of CTGF was observed and DAPT (a potent Notch inhibi-
tor) further reduced CTGF expression marginally in these cell types (Fig 5A and 5B). In response
to TGF-β2 agonist (human recombinant protein), the CTGF expression increased about 2-fold
in hASMCs and 100-fold in mouse fibroblasts. Pre-treatment of hASMCs with DAPT signifi-
cantly reduced such induction of CTGF expression (Fig 5A and 5B). In contrast, SB431542, an
inhibitor of activin receptor-like kinase (ALK5; the TGF- β type I receptor) reduced the expres-
sion of CTGF in both cell types ~50% below basal expression. No significant effect of DAPT was
observed in response to SB431542 probably because of very low expression of CTGF.
Next, we performed transfection studies on hASMCs using plasmids for NICD or a domi-
nant negative form of the MAML activator (dnMAML) to overexpress or downregulate Notch
signaling respectively. NICD-plasmid increased the expression of Notch1 by almost 250-fold
and CTGF expression by 2-fold in the hASMCs (Fig 5C and 5D). Conversely, dnMAML-medi-
ated knockdown of Notch signaling did not significantly affect CTGF expression (Fig 5C and
5D). In contrast, siRNA-mediated specific knockdown of Notch1 resulted in a more than 50%
reduction in CTGF expression (Fig 5G and 5H). The discrepancy between the dnMAML and
siRNA for Notch1 may be attributed to either inhibitory effects of dnMAML on other Notch
family members including Notch2 and Notch3, or potential non-canonical activities of Notch1
that are affected by dnMAML. Further, siRNA for Notch3 did not affect the expression of
(A-D) and osteopontin (F-I) as markers of contractile or synthetic-phenotype marker of SMCs, respectively. IHC staining with antibody against
Mmp12 (K-N), and Ctgf (P-S) performed on cross sections of abdominal aortae isolated from Apoe-/- cell-specific Notch1 haploinsufficient
Apoe-/- mice after 28 days AngII treatment. Scale bars = 50 μm. The IHC for respective immunostaining was quantified using ‘Fiji’ version of
image J (E, J, O, T). Bar graphs represent fold change in gene expression of Ctgf (W), Tgf-β1 (X), Tgf-β2 (Y), Smad2 (Z) and Smad3 (AA) using
mRNA obtained from aortae of Apoe-/- and cell-specific Notch1 haploinsufficient mice. The results were standardized to Rpl13a and reported as
ratio to saline-treated mice (mean ± SEM, n = 3 for each group). (AB) Fold change in Ctgf expression in SMCs isolated from Apoe-/- and
Notch1+/-;Apoe-/- mice at basal levels and in the presence of TNF-α. ***P<0.001; **P<0.01; and *P<0.05 (ordinary ANOVA followed by a
Bonferroni-Holm multiple comparisons test).
https://doi.org/10.1371/journal.pone.0178538.g003
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CTGF significantly (Fig 5I). However, decreased expression of smoothelin (a contractile
smooth muscle marker) was observed with Notch3 siRNA (Fig 5J). Interestingly, the expres-
sion of Notch3 and smoothelin was also increased by almost 2-fold with NICD overexpression
(Fig 5E and 5F). No synergistic effects of Notch1 and Notch3 inhibition were observed on the
expression of CTGF and smoothelin as determined by the treatment of hASMCs with a com-
bination of siRNA for both Notch1 and Notch3 (Fige 5G–5J). Next, we investigated if the
alteration in gene expression of CTGF is translated in the change in protein content. Western
Blotting was performed to observe this change. Reduced protein contents of CTGF were
observed in Notch1+/- SMCs and hASMCs treated with DAPT (S8 Fig). In accordance with
the gene expression data, Tgf-β2 increased the CTGF protein contents, whereas reduced
Fig 4. CTGF expression in human AAA correlates strongly with synthetic SMC-phenotype. (A-D) Immunohistochemical staining for CTGF on the
normal and aneurysmal human abdominal aorta sections. (E-P) Micrographs showing immunofluorescence staining for CTGF (green; E, I, M) and fibroblast
marker TE-7 (red; E, J, N) on the tissue sections obtained from medial layer of healthy human controls (E-H) or aneurysmal (I-L) or non-aneurysmal aorta
(M-P) from same human AAA. Merged images of CTGF and TE-7 staining from respective tissues (yellow; G, K, O) and nuclear staining (DAPI; H, L, P) are
shown. Scale bars = 50 μm.
https://doi.org/10.1371/journal.pone.0178538.g004
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Fig 5. Gain- and loss-of-function studies suggest direct involvement of Notch1 in regulating CTGF expression. (A-B) Bar
graphs represent fold change in gene expression of CTGF in the human aortic smooth muscle cells (A) and mouse embryonic
Cell-specific Notch1 haploinsufficiency
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CTGF contents were observed in hASMCs with SB-431542, an inhibitor of Tgf- β signaling
(S8A and S8B Fig). Reduced CTGF content was observed in SMCs with Notch1 deficiency
under all these conditions. Overexpression of NICD reversed the protein contents of CTGF
in hASMCs (S8C Fig). Collectively, our data suggest that Notch1 may be directly involved in
the CTGF-associated hASMC phenotype modulation.
Notch1 deficiency reduces the CTGF-induced collagen gel stiffness in
VSMCs
Previous studies have demonstrated that Notch1 signaling directly regulates CTGF in osteo-
clasts which increases fibrotic response[53]. To determine whether CTGF functionally modu-
lates a shift towards a synthetic phenotype, we performed collagen gel contraction assay using
VSMCs from the abdominal aortae of Apoe-/- and Notch1+/-;Apoe-/- mice. At basal condition,
the contraction in the collagen of the VSMCs from Apoe-/- mice was ~13% in response to 10%
FBS (Fig 6A and 6B) whereas the contraction in the collagen of the VSMCs from Notch1+/-;
Apoe-/- mice was significantly higher at ~35% (Fig 6E and 6F; P<0.001). The contraction of
collagen gel was reduced to just ~5% in the presence of CTGF in Apoe-/- VSMCs (Fig 6C and
6D), whereas in the VSMCs from Notch1+/-;Apoe-/- mice, this contraction was significantly
higher at ~10% (Fig 6G and 6H; P<0.05). We further characterized the inhibitory effect of
Notch1 on CTGF-induced changes in VSMC-phenotype using ex vivo aortic ring culture from
Apoe-/- mice and NICD plasmid or siRNA constructs[43]. Overexpression of Notch1 increased
the collagen content in the adventitial area of aortic rings as compared to the non-NICD trans-
fected aortic rings (marked with red boundary) at basal conditions (Fig 6K) and in the pres-
ence of human recombinant CTGF (Fig 6O). Transfection with siRNA Notch1 abrogated such
increase in the collagen content at basal levels (Fig 6L) and in response to recombinant CTGF
(Fig 6P) suggesting inhibitory effects of Notch1 deficiency on collagen content. Modest
increase in the adventitial collagen content was observed in the aortic rings treated with
siRNA for Notch3 and CTGF (Fig 6Q) suggesting differential effects of Notch isoforms. No
difference was observed in the collagen content in the aortic rings treated with empty plasmid
for NICD or non-specific siRNA controls (data not shown).
These findings, coupled with our observations that Notch1 overexpression is correlated
with CTGF upregulation, led us to propose that Notch1 signaling is a direct modulator of
VSMC-phenotype. These data demonstrate the ability of CTGF to inhibit the contractility
behavior of VSMCs and that inhibition of Notch1 signaling prevents such effect in a TGF-β
signaling-dependent manner, which may play a role in maintaining VSMCs in contractile
phenotype.
Discussion
In the current study, we demonstrated that Notch1 haploinsufficiency in myeloid cells
(LysM-Cre) prevented the formation of AAA and recapitulated histological traits of global
Notch1 deficiency including increased M2-differentiation of macrophages and decreased
fibroblast (B) treated with DAPT for 24 hours followed by TGF-β agonist or inhibitor SB431542 [activin receptor-like kinase (ALK5;
the TGF-beta type I receptor inhibitor] treatment for 24 hours. (C-F) Graphs represent fold change in the expression of Notch1,
CTGF, Notch3 and smoothelin in the human aortic smooth muscle cells 48 hours post transfected with Notch1 intracellular domain
(NICD) overexpressing plasmid or dominant negative mastermind like proteins (dnMAML). (G-J) Graphs represent fold change in
the expression of Notch1, CTGF, Notch3 and smoothelin in the human aortic smooth muscle cells 48 hours post transfected
siRNAs for Notch1/Notch3.The qPCR data were standardized to RPL13a and reported as ratio (mean ±SEM, n = 3 for each
group) to empty plasmids for NICD/dnMAML or non-specific siRNA. ***P<0.001, **P<0.01, *P<0.05 (ordinary ANOVA followed
by a Bonferroni-Holm multiple comparisons test). (EP = empty plasmid).
https://doi.org/10.1371/journal.pone.0178538.g005
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inflammation. Haploinsufficiency of Notch1 in SMCs (smMHC-Cre) did not prevent the AAA
formation in these mice. However, typical histological characteristics of AAA including elastin
Fig 6. Notch1 deficiency reduces the CTGF-induced collagen gel stiffness in SMCs. (A-H) Photographs depict contractility of collagen gel embedded
with VSMCs isolated from Apoe-/- and Notch1+/-;Apoe-/- mice. VSMCs cultured in a 6-well plate and treated with or without CTGF (10 ng/ml) for 72 hours and
resuspended in a collagen solution at a concentration of 6 x 105 cells/ml for 48 hours. After imaging, the gels were gently released from attachment and the
media was replaced with 10% FBS DMEM to induce contraction and incubated for 2 hours. The gel was imaged to determine the amount of gel contraction.
Each group is represented by 6 replicates in each experiment, and repeated in 3 independent experiments. The images were analyzed using ImageJ software
to measure the gel area at each time-point, from which the percentage decrease of gel area was determined. The yellow dotted lines represent the area of the
collagen gel. Bar graphs represent percent decrease of gel area in different treatment groups. (J-Q) Trichrome staining of the aortic rings from Apoe-/- mice
transfected with NICD, siRNA for Notch1 or Notch3 in the absence (J-M) or presence of CTGF (N-Q). The aortic rings were transfected with NICD, non-specific
siRNA (4390846, Invitrogen), siRNA Notch1 or siRNA Notch3 for 24 hours. The aortic rings were then treated using recombinant human CTGF protein for
additional 48 hours. The rings were then collected and processed for histology. The red dotted lines represent the adventitial layer enriched with collagen
contents. Scale bars = 50 μm. ***P<0.001, *P<0.05 (ordinary ANOVA followed by a Bonferroni-Holm multiple comparisons test).
https://doi.org/10.1371/journal.pone.0178538.g006
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fragmentation and aortic remodeling were minimal in SMC-Notch1+/-;Apoe-/- mice as com-
pared to Apoe-/- mice with AngII. Also, Notch1 haploinsufficiency in SMCs was associated
with increased expression of contractile markers of SMC-phenotype and concomitant decrease
in the expression of markers of synthetic SMC-phenotype in the aorta. Expression of CTGF,
an ECM-associated protein that modulates synthetic VSMC phenotype, was significantly
increased in the abdominal aorta of Apoe-/- mice in response to AngII. SMC-specific Notch1
haploinsufficiency prevented such increase in CTGF expression. Increased expression of
CTGF was also observed in the adventitial region of the abdominal aorta in human AAA and
correlated strongly with synthetic SMC-phenotype. In vitro studies on hASMCs and fibroblasts
suggest that Notch1 modulates the expression of CTGF by a TGF-β dependent mechanism,
which seems to be independent of interactions between SMCs and macrophages. Our data
suggest that lack of Notch1 in myeloid cells is sufficient to prevent the formation of AAA
whereas SMC-specific Notch1 haploinsufficiency limits dilation of the abdominal aorta by
maintaining contractile SMC phenotype and preventing matrix remodeling (Fig 7).
Extensive studies using mouse models of AAA and our published data using bone marrow
transplantation approaches have shown widespread inflammatory macrophages as major cel-
lular components at the onset of the disease[10, 32, 33, 54]. Progression of aneurysm is, how-
ever, considered to be interplay between the destruction of elastin and collagen in the media
and adventitia and apoptotic cell death of medial SMCs along with thinning of the vessel wall
[48]. Some studies have reported that anti-inflammatory interventions in AAA may even
accelerate disease progression[55]. However, the specific role of various cell populations of
vascular origin in aneurysmal disease remains uncertain. We hypothesize that along with
Fig 7. Schematic diagram of the study. The dashed arrows depict the mechanistic pathways to be tested in the study.
We propose that myeloid specific Notch1 haploinsufficiency prevents aneurysm development by modulating macrophage
polarization. SMC-specific Notch1 haploinsufficiency interferes with the progression of aneurysm by modulating CTGF-
dependent SMC-phenotype. (Mφ: macrophages, SMC: smooth muscle cells; CTGF, connective tissue growth factor, opn:
osteopontin,vim: vimentin).
https://doi.org/10.1371/journal.pone.0178538.g007
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transmural infiltration of inflammatory cells at the early stages of the disease, SMCs contribute
to the expansion of aneurysmal growth by participating in the degradation of ECM and increa-
sing the aortic stiffness. Notch1 deficiency in SMCs may interfere with the aortic expansion
initiated by the influx of inflammatory macrophages. It is not clear however, if these two fac-
tors act independently of each other or macrophages influence SMC by the release of chemo-
kines and cytokines. Some studies have demonstrated that macrophage infiltration induces
SMC apoptosis and increased MMP activity, thus contributing to aneurysmal expansion[56].
While our data and other studies have shown that SMCs are independent and actively partici-
pate in the process of degrading the aortic matrix[48, 49]. Interestingly, in humans, anti-
inflammatory treatment has not been successful in preventing AAA progression making
VSMCs an appealing target for further detailed study[57, 58]. Whilst synthetic VSMCs secrete
ECM proteins including collagens and elastin, they also secrete MMPs that are involved in
ECM breakdown activities[48, 59]. The migration of medial SMCs into intima and media has
been shown to play a decisive role in the progression of vascular diseases[60]. Obviously,
because of the complexity of AAA pathophysiology and numerous pathways involved in the
AAA formation and progression, mere decrease in the inflammatory macrophages may not be
sufficient to repair pre-existing aortic dilation and elastin degradation.
Studies have shown that matricellular proteins such as CTGF play an important role in vas-
cular remodeling by regulating ECM deposition, cell proliferation, and de-differentiation of
contractile SMC to synthetic SMC phenotype[61]. In human ascending aortic aneurysms,
increased reactive oxygen species (ROS) accumulation correlates with media layer degenera-
tion and increased CTGF expression, which modulate the synthetic VSMC phenotype[50]. In
addition, CTGF is also involved in monocyte migration and adhesion to injured vessel wall[50,
51]. Our findings are consistent with the previous studies and suggest that CTGF protein is
overexpressed in the progression of AAA and correlates with synthetic SMCs[50, 62]. We pos-
tulate that Notch1 deficiency in the SMCs decreases the CTGF expression thus protecting
against the expansion of aneurysm (Fig 7). Although the mechanism by which CTGF expres-
sion is induced in this mouse model is still obscure, possible upregulation of CTGF could be
achieved by AngII or by oxidative stress in the medial layers of AAA[50]. Various fibrogenic
stimuli including TGF-β, thrombin or mechanical stretch have also been reported to induce
CTGF expression. Further studies may be required to define the precise mechanism by which
CTGF is activated in the setting of vascular diseases including AAA.
The opposite effects of SMC-specific Notch1 haploinsufficiency on Smad2 and Smad3 indi-
cate that the crosstalk between Notch1 and Tgf-β signaling pathway in aneurysm may have dif-
ferential effects on the downstream targets. Indeed, studies have shown that loss of Smad3 in a
mouse model drastically increases wall thickening of the abdominal aorta accompanied by ves-
sel wall remodeling with elastin fragmentation[63]. Studies by Canalis et al[53] have shown
that Notch activation directly induces CTGF expression in osteoblasts, and that these two plu-
ripotent pathways may act in concert to regulate osteogenic homeostasis. It will be interesting
to see if these interactions play a causal role in vascular diseases. In summary, our findings sup-
port the hypothesis that CTGF may play a role in AAA pathogenesis by promoting SMC differ-
entiation into proliferative and apoptotic phenotype leading to aortic expansion and thus
making CTGF a potential target for future therapies targeting SMC-phenotypic modulation.
Our present work demonstrates that Notch1, not Notch3 is involved in the CTGF-mediated
synthetic phenotypic modulation of SMCs. Furthermore, the differential roles of Notch1 in
various vascular cells observed in our study demonstrate the complexity of Notch signaling
and warrant detailed future studies into the individual contributions of Notch receptors in
each vascular cell type on AAA development (Fig 7). Taken together, these data suggest that
Notch1 signaling has differential effects on SMC phenotype and provide strong evidence that
Cell-specific Notch1 haploinsufficiency
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the phenotypic modulation of SMC-phenotype can influence AAA progression. These studies
might prove useful in the future for tailored cell-specific therapy and improve therapeutic effi-
cacy to mitigate the deleterious effects of AAA progression.
Supporting information
S1 Fig. Endothelial cell (EC)-specific Notch1 haploinsufficiency does not affect AAA devel-
opment in AngII-induced mouse model. (A) Representative images of the cross-section of
the abdominal aorta of the EC-specific Notch1 haploinsufficient Apoe-/- mice 28 days after
AngII treatment. H&E staining showing transmural inflammatory cell infiltration; elastin
staining showing fragmentation of the elastin fibers; trichrome staining showing presence of
collagen fibers (blue) interspersed within the medial and adventitial layer. Survival graphs rep-
resent percentage survival in cell-specific Notch1+/-;Apoe-/- as compared to Apoe-/- mice during
28 days AngII infusion. Scale bar, 1 mm in (A), 50 μm in B-E.
(TIF)
S2 Fig. SMC-specific Notch1 haploinsufficiency does not affect dilatation of proximal
aorta in AngII-induced mouse model. Representative aortae isolated from Apoe-/- mice (A);
Mφ-Notch1+/-;Apoe-/- mice (B); SMC-Notch1+/-;Apoe-/- mice (C); or EC-Notch1+/-;Apoe-/- mice
(D) treated with AngII (28 d treatment). Images were taken using Zeiss Stemi 2000-C micro-
scope. Scale bar, 1 mm. Quantitative measurement of maximal aortic width (mm) of different
groups at the ascending aorta (E), aortic arch (F), and descending aorta (G). Each symbol rep-
resents an individual animal. Mean and SEM are shown. Representative images of the cross-
section of the abdominal aorta of different groups 28 d after AngII treatment with H&E stain-
ing (H-S). Scale bar, 1 mm (A-D), 50 μm in H-S.
(TIF)
S3 Fig. Cell-specific Notch1 haploinsufficiency reduces matrix metalloproteinase produc-
tion and prevents apoptotic cell death. Immunohistochemical staining for Mmp2 (A-D),
Mmp9 (E-H) and active caspase-3 (I-L) performed on cross section of abdominal aortae iso-
lated from Apoe-/- and cell-specific Notch1 haploinsufficient Apoe-/- mice after 28 d AngII treat-
ment. Scale bars = 50 μm.
(TIF)
S4 Fig. Notch1 haploinsufficiency prevents LPS-induced apoptotic cell death of SMCs.
Cells were grown at ~70% confluence, and treated with LPS (100 ng/ml for 24 h). The cells
were collected, stained with annexin V-FITC (5 μl/1x105 cells suspended in 100 μl) in binding
buffer for 20 min in the dark, washed 3 times with PBS, and incubated in PI solution (5 μl/100
μl) immediately before 10,000 events were acquired in a Becton Dickinson LSRII flow cytome-
ter (A, B). The percentage of annexin V-positive/PI-negative were quantified with Flow Jo
software. Bar graphs show data (mean ± SEM) from three independent experiments (C).
(TIF)
S5 Fig. Myeloid-specific Notch1 haploinsufficiency promotes M2-polarozation of macro-
phages. Immunohistochemical staining for NICD (A-D), M1 macrophage marker, Irf8 (E-H)
and Mcp1 (I-L) and M2 macrophage marker, Cd206 (M-P). Bar graphs represent fold change
expression of iNos (Q) and Arg1 (R) in the aorta of AngII treated Apoe-/- and cell-specific
Notch1 haploinsufficient Apoe-/- mice. The qPCR data were standardized to Rpl13 and reported
as ratio (mean ± SEM, n = 3 for each group) to empty plasmids for NICD/dnMAML or non-
specific siRNA. P<0.001, P<0.01, P<0.05. Scale bars = 50 μm.
(TIF)
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S6 Fig. SMC-specific Notch1 haploinsufficiency preserves contractile-phenotype of SMCs.
Immunohistochemical staining for contractile smooth muscle cell (SMC) phenotype marker,
smooth muscle-alpha-actin (SMA-α; A-D) and synthetic SMC marker, vimentin (E-H) per-
formed on cross section of abdominal aortae isolated from cell-specific Notch1 haploinsuffi-
cient Apoe-/- mice after 28 d AngII treatment. Scale bars = 50 μm.
(TIF)
S7 Fig. SMC-specific Notch1 haploinsufficiency decreases the expression of CTGF in
TGFβ-dependent manner. (A) Western blot for Ctgf in WT and Notch1 haploinsufficient
SMCs, (B) CTGF protein expression in human aortic smooth muscle cells treated with DAPT
for 24 hours followed by TGF-β agonist or inhibitor SB431542 [activin receptor-like kinase
(ALK5; the TGF-β type I receptor inhibitor] treatment for 24 hours. (C) CTGF protein expres-
sion in human aortic smooth muscle cells 48 hours post transfected with Notch1 intracellular
domain (NICD) overexpressing plasmid. GAPDH was used as a loading control for protein
normalization in Western blotting in A-C.
(TIF)
S8 Fig. Macrophages from either WT or Notch1+/- mice did not influence the expression of
synthetic-phenotype of SMCs. Bar graphs represent fold change in gene expression of Ctgf
(A), smMHC (B), Mmp12 (C), vimentin (D) using mRNA obtained from WT SMCs co-cul-
tured with WT or Notch1+/- bone marrow derived macrophages (BMDMs) in the absence or
presence of LPS/IFN-γ.
(TIF)
S1 Table. Schematic presentation to generate cell-specific Notch1 haploinsufficient mice
on Apoe-/- background.
(TIF)
S2 Table. List of primer sequences used in genotyping (as suggested by Jackson lab).
(TIF)
S3 Table. Genotyping for cell-specific Notch1 haploinsufficient mice.
(TIF)
S4 Table. List of antibodies used for immunohistochemistry and immunofluorescence.
(TIF)
S5 Table. List of primer sequences used in quantitative real-time reverse transcriptase
PCR studies.
(TIF)
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